Judge Axes IP Suit Over Xifaxan, Ruling The Drug Is Prior Art
A New Jersey federal judge on Wednesday dismissed an infringement suit against Bausch Health unit Salix Pharmaceuticals Ltd. over its drug Xifaxan after finding the drug product actually constitutes prior art...To view the full article, register now.
Already a subscriber? Click here to view full article